The multi-resistant opportunistic bacterium Pseudomonas aeruginosa has been identified by the WHO as one of the most threatening pathogens of our time, and a priority for the development of new treatments. Biofilms produced by this micro-organism act as protective barriers. They increase both its pathogenicity via a persistence towards the immune system and its resistance to antibiotics. Biofilm formation is coordinated by the Quorum Sensing (QS) that is a bacterial communication network responsible for virulence pathways expression according to the population density. In P. aeruginosa specific QS system pqs, the transcription factor PqsR regulates the activation of virulence-related genes via recognition of its auto-inducer PQS (Pseudomonas Quinolone Signal). This circuit stimulates the secretion of virulence factors like pyocyanin as well as the establishment of biofilms. Therefore, the development of non-bactericidal agents that disrupt QS connections appears as a promising alternative to conventional medicines, without creating selection pressure issues. These new anti-virulence agents (AVAs) could restore the efficacy of antibiotics when used in combination therapy. In particular, the design of AVAs that inhibit PqsR appears to be a sustainable approach to combat P. aeruginosa specifically. Bi-aromatic PqsR inhibitors possessing a 4-aminoquinoline moiety have been described in the literature. Meanwhile, our team recently discovered a series of 2-heteroaryl-4-quinolones that display interesting anti-biofilm and anti-pyocyanin activities. We now aim at developing a family of 2-heteroaryl-4-aminoquinolines as new AVAs potentially inhibiting PqsR. The synthesis as well as the physicochemical and biological evaluation of those novel molecules will be described in the poster.
Previous Article in event
Molecular Dynamic Simulations Based Conformational Analysis and Binding study of CP-225917 on Farnesyl Transferase enzymePrevious Article in session
Next Article in event Next Article in session
Development of new anti-virulence agents to tackle multi-resistant Pseudomonas aeruginosa.
Published: 01 November 2022 by MDPI in 8th International Electronic Conference on Medicinal Chemistry session General
Keywords: Multi-resistant bacteria; Pseudomonas aeruginosa; Biofilm; Quorum Sensing; anti-virulence agents.